Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
OPKO Health Inc banner

OPKO Health Inc
NASDAQ:OPK

Watchlist Manager
OPKO Health Inc Logo
OPKO Health Inc
NASDAQ:OPK
Watchlist
Price: 1.225 USD -1.21% Market Closed
Market Cap: $940.4m
Write Note Create Alert Ask AI
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

OPK Price Targets Summary
OPKO Health Inc

Wall Street analysts forecast OPK stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for OPK is 3.743 USD with a low forecast of 1.616 USD and a high forecast of 8.925 USD.

OPK Lowest Forecast
Wall Street Target
1.616 USD
32% Upside
OPK Average Forecast
Wall Street Target
3.743 USD
206% Upside
OPK Highest Forecast
Wall Street Target
8.925 USD
629% Upside
Lowest
Price Target
1.616 USD
32% Upside
Average
Price Target
3.743 USD
206% Upside
Highest
Price Target
8.925 USD
629% Upside
OPKO Health Inc Competitors:
Price Targets
MASI
Masimo Corp
38% Upside
STRO
Sutro Biopharma Inc
147% Upside
UFPT
UFP Technologies Inc
11% Upside
AFYA
Afya Ltd
17% Upside
MASI
Masimo Corp
38% Upside
STRO
Sutro Biopharma Inc
147% Upside
UFPT
UFP Technologies Inc
11% Upside
AFYA
Afya Ltd
17% Upside
VAC
Pierre et Vacances SA
25% Upside

Revenue
Forecast

28% / Year
Past Growth
-2% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss
28% / Year
Past Growth
-2% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss

For the last 13 years the compound annual growth rate for OPKO Health Inc's revenue is 28%. The projected CAGR for the next 4 years is -2%.

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
9%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
9%
Average Beat

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-13%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-13%
Average Miss

What are analyst estimates?

See Also

Summary
OPK intrinsic value, competitors valuation, and company profile.
DCF Valuation
OPK stock valuation using Discount Cash Flow valuation method.
Relative Valuation
OPK stock valuation using valuation multiples.
Wall Street Estimates
OPK price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
OPK stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is OPK's stock price target?
Price Target
3.743 USD

According to Wall Street analysts, the average 1-year price target for OPK is 3.743 USD with a low forecast of 1.616 USD and a high forecast of 8.925 USD.

What is OPKO Health Inc's Revenue forecast?
Projected CAGR
-2%

For the last 13 years the compound annual growth rate for OPKO Health Inc's revenue is 28%. The projected CAGR for the next 4 years is -2%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 316,400+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.